神经内分泌分化介导乳腺癌HER2靶向治疗逃逸
该研究在乳腺癌中发现神经内分泌分化(NED)是治疗逃逸途径之一,22%的进展病例出现神经内分泌特征,以HER2阳性亚型为主。通过类器官和异种移植模型揭示EpCAM表观沉默、HER2扩增及NEUROD1调控的神经内分泌命运,并发现FGFR1依赖可作为干预靶点。
要点
- 22%的进展乳腺癌病例出现神经内分泌特征,以HER2阳性亚型为主。
- NED涉及EpCAM表观沉默和HER2扩增,NEUROD1为神经内分泌命运主调控因子。
- 神经内分泌肿瘤细胞依赖FGFR1,与NCAM-FGFR1相互作用相关。
核心结论
- NED是乳腺癌HER2靶向治疗逃逸的机制之一,对疾病监测和干预有提示意义。
研究设计与样本
- 研究采用患者来源的上皮/神经内分泌类器官和异种移植模型。
- 在进展病例中分析神经内分泌特征的出现或增加。
主要发现
- 22%的进展病例出现或增加神经内分泌特征,主要但不限于HER2阳性亚型。
- NED涉及EpCAM和扩增HER2的表观沉默,NEUROD1为神经内分泌命运的主转录调控因子。
- 在EpCAM检测失败的患者中检出NCAM阳性候选循环肿瘤细胞。
- 神经内分泌肿瘤细胞显示与NCAM-FGFR1相互作用及间充质FGFR1剪接相关的FGFR1依赖。
临床怎么用
- 对HER2靶向治疗进展的乳腺癌患者,可考虑评估神经内分泌分化特征。
- EpCAM-based检测失败时,可探索NCAM作为循环肿瘤细胞检测标志。
- FGFR1依赖为神经内分泌分化肿瘤提供潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neuroendocrine differentiation (NED) promotes lineage plasticity and therapy resistance in prostate and lung cancers. Here we identify NED as a route of treatment escape in breast cancer: neuroendocrine features emerged or increased in 22% of progressive cases, predominantly, but not exclusively, in HER2-positive subtype. Using patient-derived, epithelial/neuroendocrine organoid and xenograft models, we map the epigenetic and transcriptional divergence between epithelial and neuroendocrine states arising from a shared mutational background and define a breast cancer neuroendocrine signature. NED involves epigenetic silencing of EpCAM and amplified HER2, while NEUROD1 functions as a master transcriptional regulator of the neuroendocrine fate. NCAM-positive putative circulating tumor cells were detected in patients in whom EpCAM-based detection had failed. Neuroendocrine tumor cells exhibit an FGFR1 dependency associated with NCAM-FGFR1 interaction and mesenchymal FGFR1 splicing. Together, these findings establish NED as a mechanism of escape from HER2-targeted therapy in breast cancer, with implications for disease monitoring and intervention.
引用
- Würth, Cheytan, Schwerd-Kleine, et al. Neuroendocrine Differentiation Mediates Escape from HER2-Targeted Therapy in Breast Cancer. Cancer Discov. 2026. PMID: 42949420. doi:10.1158/2159-8290.CD-26-1312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。